HPSE and mesothelioma: Notably, the heparanase inhibitors pixatimod (PG545) and defibrotide appeared more effective than cisplatin, a common chemotherapeutics in mesothelioma, in restraining tumor growth, closely associating with a profoundly prolonged survival of mesothelioma-bearing mice.